Elevated circulating CD14(low)CD16(+) monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26403460)

Published in Clin Exp Med on September 24, 2015

Authors

Anping Peng1, Peifeng Ke1, Rong Zhao1, Xinyi Lu1, Cheng Zhang1, Xianzhang Huang1, Guangjun Tian2, Jun Huang3, Jinli Wang4, Pietro Invernizzi5,6, Qubo Chen7, Junhua Zhuang8

Author Affiliations

1: Department of Laboratory Science, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Road, Guangzhou, 510120, China.
2: Department of Hepatology, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
3: Department of Pathogenic Biology and Immunology, Institute of Immunology, Guangzhou Medical University, Guangzhou, China.
4: Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou, China.
5: Liver Unit and Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzanno, Italy.
6: Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA, USA.
7: Biological Resource Center, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. qubochen326@163.com.
8: Department of Laboratory Science, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Road, Guangzhou, 510120, China. Zjh2208@163.com.

Articles cited by this

C-reactive protein: a critical update. J Clin Invest (2003) 11.77

Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol (2008) 7.21

Nomenclature of monocytes and dendritic cells in blood. Blood (2010) 6.63

The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol (2006) 5.50

The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol (2002) 3.75

Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci U S A (2007) 2.92

Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood (2011) 2.74

SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood (2011) 2.66

The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood (1993) 2.62

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology (2014) 2.40

The three human monocyte subsets: implications for health and disease. Immunol Res (2012) 2.08

Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One (2010) 1.94

The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum (2012) 1.85

In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A (2009) 1.84

Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol (2009) 1.40

Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol (2009) 1.31

CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology (2005) 1.22

Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease. Inflamm Bowel Dis (2007) 1.16

IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology (2014) 1.15

Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS One (2011) 1.09

CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm (2014) 1.03

CD16+ monocytes control T-cell subset development in immune thrombocytopenia. Blood (2012) 0.99

Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol (2000) 0.93

IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures. J Immunol (2012) 0.91

Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes. BMC Gastroenterol (2012) 0.91

Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun (2007) 0.90

CD16 regulates TRIF-dependent TLR4 response in human monocytes and their subsets. J Immunol (2012) 0.89

Innate immunity and primary biliary cirrhosis. Curr Mol Med (2009) 0.89

Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis. World J Gastroenterol (2009) 0.87

Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice. Hepatology (2014) 0.83

Adenosine deaminase isoenzymes in liver disease. Am J Gastroenterol (1993) 0.83

Predicting outcome in primary biliary cirrhosis. Ann Hepatol (2014) 0.82

Transcriptomic network support distinct roles of classical and non-classical monocytes in human. Int Rev Immunol (2014) 0.81

Respective value of alkaline phosphatase, gamma-glutamyl transpeptidase and 5' nucleotidase serum activity in the diagnosis of cholestasis: a prospective study of 80 patients. J Clin Gastroenterol (2000) 0.79

[Adenosine deaminase activity--an indicator of inflammation in liver disease]. Dtsch Z Verdau Stoffwechselkr (1987) 0.77

[Enzymatic activity of serum adenosine deaminase in different liver disorders]. An Med Interna (1989) 0.77

Altered expression of alkaline phosphatase (ALP) in the liver of primary biliary cirrhosis (PBC) patients. Hepatol Res (2006) 0.77